These photos will blow your mind.
Solid Biosciences delivers its largest scientific program at the 2026 ASGCT Annual Meeting with 5 oral presentations and 11 posters - ...
During ALS Awareness Month this May, the Muscular Dystrophy Association (MDA) is highlighting unprecedented scientific progress, inspiring personal stories, legislative advocacy, and national ...
Boye (muscular) was forced off in the fourth minute of Saturday's clash against Mallorca, leaving his availability for upcoming fixtures uncertain. Analysis: Boye's early exit is a concerning ...
SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular ...
The MarketWatch News Department was not involved in the creation of this content.-- ImmunoForge's LMT15 Platform combines high BBB permeability with proprietary long-acting ELP te ...
Roche is launching a phase III trial for its gene therapy Elevidys after European regulators halted its approval due to safety concerns. The study seeks additional data to address the European ...
Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced today a partnership with Evolyra Therapeutics to ...
ETHealthworld.com brings latest muscular dystrophy news, views and updates from all top sources for the Indian Health ...
The Phase 1/2 FUNCTION-DMD study will enroll ambulatory patients and is designed to evaluate safety, tolerability, and efficacy, including dystrophin protein expression and functional outcomes. "The ...
March (undisclosed) suffered a minor muscular setback in training that ruled him out of the squad for Saturday's clash against Tottenham and will also miss Tuesday's clash against Chelsea, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results